Array Biopharma Inc. has a market cap of $192.69 million; its shares were traded at around $3.81 with and P/S ratio of 7.71.
ARRY is in the portfolios of Jean-Marie Eveillard of Arnhold & S. Bleichroeder Advisers, LLC, Jim Simons of Renaissance Technologies LLC.
CFO Recent Trades:
- Sell:: CFO Michael Carruthers sold 1,661 shares of ARRY stock on 03/23/2010 at the average price of 2.46, the price of the stock has increased by 54.88% since.
- Sell:: CFO Michael Carruthers sold 1,707 shares of ARRY stock on 02/23/2010 at the average price of 2.4, the price of the stock has increased by 58.75% since.
- Sell:: CFO Michael Carruthers sold 6,286 shares of ARRY stock on 02/05/2010 at the average price of 2.44, the price of the stock has increased by 56.15% since.
- Sell:: CFO Michael Carruthers sold 1,644 shares of ARRY stock on 01/22/2010 at the average price of 2.49, the price of the stock has increased by 53.01% since.
- Sell:: CFO Michael Carruthers sold 5,681 shares of ARRY stock on 01/06/2010 at the average price of 2.69, the price of the stock has increased by 41.64% since.







RSS